Eidelman Virant Capital Teva Pharmaceutical Industries LTD Transaction History
Eidelman Virant Capital
- $136 Million
- Q3 2022
A detailed history of Eidelman Virant Capital transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Eidelman Virant Capital holds 46,718 shares of TEVA stock, worth $817,565. This represents 0.28% of its overall portfolio holdings.
Number of Shares
46,718
Previous 46,718
-0.0%
Holding current value
$817,565
Previous $329,000
15.5%
% of portfolio
0.28%
Previous 0.24%
Shares
3 transactions
Others Institutions Holding TEVA
# of Institutions
617Shares Held
563MCall Options Held
25.2MPut Options Held
5.08M-
Black Rock Inc. New York, NY43MShares$752 Million0.02% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E936.3MShares$636 Million41.14% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L332.3MShares$566 Million5.5% of portfolio
-
Menora Mivtachim Holdings Ltd.28.8MShares$505 Million3.23% of portfolio
-
Exor Capital LLP London, X026.5MShares$463 Million15.49% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $19.4B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...